Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI

American Journal of Roentgenology

Volumn 201, Issue 5, 2013, Pages 1115-1119

  Rakheja, Rajan ^a   Chandarana, Hersh ^a   DeMello, Linda ^a   Jackson, Kimberly ^b   Geppert, Christian ^b   Faul, David ^b   Glielmi, Christopher ^b   Friedman, Kent P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Siemens Healthcare   (United States)

Author keywords

Apparent diffusion coefficient; MRI; PET CT; PET MRI; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE;

AGED; ARTICLE; BONE METASTASIS; BREATHING PATTERN; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG DISTRIBUTION; DRUG TUMOR LEVEL; DRUG UPTAKE; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; IMAGING SYSTEM; INTERMETHOD COMPARISON; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIMARY TUMOR; PRIORITY JOURNAL; SOFT TISSUE CANCER; SOLID TUMOR; STANDARD UPTAKE VALUE; WHOLE BODY MRI; WHOLE BODY PET;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MULTIMODAL IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84886572756     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11304     Document Type: Article

References (29)

1. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42(5 suppl):1S-93S
2. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 2007; 48(suppl 1):78S-88S
3. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379
4. Folpe AL, Lyles RH, Sprouse JT, et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000; 6:1279-1287
5. 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR 2012; 198:1409-1416
6. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR 2006; 27:1419-1425
7. Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224:177-183
8. Rubesova E, Grell AS, De Maertelaer V, et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006; 24:319-324
9. Pickles MD, Gibbs P, Sreenivas M, et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 2006; 23:130-134
10. Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005; 15:71-78
11. Di Costanzo A, Scarabino T, Trojsi F, et al. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 2006; 48:622-631
12. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 2005; 102:16759-16764
13. Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC. Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging 2009; 36:200-208
14. Wu X, Korkola P, Pertovaara H, et al. No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study. Eur J Radiol 2011; 79:e117-e121
15. Nakajo M, Kajiya Y, Kaneko T, et al. FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging 2010; 37:2011-2020
16. Gu J, Khong P, Wang S, et al. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imaging Biol 2011; 13:1020-1028
17. Mori T, Nomori H, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 2008; 3:358-364
18. 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer. J Nucl Med 2011; 52:1056-1062
19. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline. Eur J Cancer 2009; 45:228-247
20. Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 2004; 45:1431-1434
21. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25:579-586
22. Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 2003; 45:208-213
23. Squillaci E, Manenti G, Di Stefano F, et al. Diffusion-weighted MR imaging in the evaluation of renal tumours. J Exp Clin Cancer Res 2004; 23:39-45
24. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009; 15:986-994
25. Liu Y, Bai R, Sun H, et al. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 2009; 64:1067-1074
26. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma: a pilot study - comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography. NMR Biomed 2011; 24:1181-1190
27. Tateishi U, Gamez C, Dawood S, et al. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology 2008; 247:189-196
28. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16:3375-3379
29. Samarin A, Burger C, Wollenweber SD, et al. PET/MR imaging of bone lesions: implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging 2012; 39:1154-1160